Last reviewed · How we verify

adult human mesenchymal stem cells

Mesoblast, Inc. · Phase 2 active Small molecule

adult human mesenchymal stem cells is a Small molecule drug developed by Mesoblast, Inc.. It is currently in Phase 2 development. Also known as: PROCHYMAL.

At a glance

Generic nameadult human mesenchymal stem cells
Also known asPROCHYMAL
SponsorMesoblast, Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about adult human mesenchymal stem cells

What is adult human mesenchymal stem cells?

adult human mesenchymal stem cells is a Small molecule drug developed by Mesoblast, Inc..

Who makes adult human mesenchymal stem cells?

adult human mesenchymal stem cells is developed by Mesoblast, Inc. (see full Mesoblast, Inc. pipeline at /company/mesoblast-inc).

Is adult human mesenchymal stem cells also known as anything else?

adult human mesenchymal stem cells is also known as PROCHYMAL.

What development phase is adult human mesenchymal stem cells in?

adult human mesenchymal stem cells is in Phase 2.

Related